These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 26636331)

  • 1. Patient characteristics, disease burden, and medication use in stage 4 - 5 chronic kidney disease patients.
    Wetmore JB; Peng Y; Jackson S; Matlon TJ; Collins AJ; Gilbertson DT
    Clin Nephrol; 2016 Feb; 85(2):101-11. PubMed ID: 26636331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, treatment patterns, and healthcare resource utilization in Medicare and commercially insured non-dialysis-dependent chronic kidney disease patients with and without anemia in the United States.
    St Peter WL; Guo H; Kabadi S; Gilbertson DT; Peng Y; Pendergraft T; Li S
    BMC Nephrol; 2018 Mar; 19(1):67. PubMed ID: 29544446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of 30-Day All-Cause Readmission with Long-Term Outcomes in Hospitalized Older Medicare Beneficiaries with Heart Failure.
    Arundel C; Lam PH; Khosla R; Blackman MR; Fonarow GC; Morgan C; Zeng Q; Fletcher RD; Butler J; Wu WC; Deedwania P; Love TE; White M; Aronow WS; Anker SD; Allman RM; Ahmed A
    Am J Med; 2016 Nov; 129(11):1178-1184. PubMed ID: 27401949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient characteristics and initiation of mineralocorticoid receptor antagonists in patients with chronic kidney disease in routine clinical practice in the US: a retrospective cohort study.
    Blankenburg M; Fett AK; Eisenring S; Haas G; Gay A
    BMC Nephrol; 2019 May; 20(1):171. PubMed ID: 31096928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comorbidity ascertainment from the ESRD Medical Evidence Report and Medicare claims around dialysis initiation: a comparison using US Renal Data System data.
    Krishnan M; Weinhandl ED; Jackson S; Gilbertson DT; Lacson E
    Am J Kidney Dis; 2015 Nov; 66(5):802-12. PubMed ID: 26015277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
    Go AS; Yang J; Ackerson LM; Lepper K; Robbins S; Massie BM; Shlipak MG
    Circulation; 2006 Jun; 113(23):2713-23. PubMed ID: 16754803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality, Kidney Failure, and Hospitalization Among Medicare Beneficiaries With CKD and Pulmonary Hypertension.
    Navaneethan SD; Walther CP; Gregg LP; Bansal S; Winkelmayer WC; Nambi V; Niu J
    Am J Kidney Dis; 2021 Nov; 78(5):700-708.e1. PubMed ID: 33905766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Clinical Outcomes of Catheter Ablation of Atrial Fibrillation in Patients With Chronic Kidney Disease.
    Ullal AJ; Kaiser DW; Fan J; Schmitt SK; Than CT; Winkelmayer WC; Heidenreich PA; Piccini JP; Perez MV; Wang PJ; Turakhia MP
    J Cardiovasc Electrophysiol; 2017 Jan; 28(1):39-48. PubMed ID: 27782345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Renal Disease on Patients with Hepatitis C: A Retrospective Analysis of Disease Burden, Clinical Outcomes, and Health Care Utilization and Cost.
    Solid CA; Peter SA; Natwick T; Guo H; Collins AJ; Arduino JM
    Nephron; 2017; 136(2):54-61. PubMed ID: 28214902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Management of Chronic Kidney Disease Patients in Italy: Results from the IRIDE Study.
    Cozzolino M; Bolasco P; Ronco C; Conte G; Menè P; Mereu MC; Di Luca M; Roccatello D; Rosati A; Jommi C; Costanzo AM; Gualberti G; di Luzio Paparatti U; Remuzzi G
    Nephron; 2018; 140(1):39-47. PubMed ID: 30016767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of ICD-9-CM codes to identify patients with comorbid chronic kidney disease in diabetes.
    Kern EF; Maney M; Miller DR; Tseng CL; Tiwari A; Rajan M; Aron D; Pogach L
    Health Serv Res; 2006 Apr; 41(2):564-80. PubMed ID: 16584465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentially Preventable Hospitalization among Patients with CKD and High Inpatient Use.
    Ronksley PE; Hemmelgarn BR; Manns BJ; Wick J; James MT; Ravani P; Quinn RR; Scott-Douglas N; Lewanczuk R; Tonelli M
    Clin J Am Soc Nephrol; 2016 Nov; 11(11):2022-2031. PubMed ID: 27821636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health Care Costs by Type of Expenditure across eGFR Stages among Patients with and without Diabetes, Cardiovascular Disease, and Heart Failure.
    Nichols GA; Ustyugova A; Déruaz-Luyet A; O'Keeffe-Rosetti M; Brodovicz KG
    J Am Soc Nephrol; 2020 Jul; 31(7):1594-1601. PubMed ID: 32487562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentially preventable hospitalization as a complication of CKD: a cohort study.
    Wiebe N; Klarenbach SW; Allan GM; Manns BJ; Pelletier R; James MT; Bello A; Hemmelgarn BR; Tonelli M;
    Am J Kidney Dis; 2014 Aug; 64(2):230-8. PubMed ID: 24731738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Higher Quality of Care on Initiation of Long-term Dialysis in Patients With CKD and Diabetes.
    Wu HY; Fukuma S; Shimizu S; Norton EC; Tu YK; Hung KY; Chen MR; Chien KL; Fukuhara S
    Am J Kidney Dis; 2017 Nov; 70(5):666-674. PubMed ID: 28764919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihyperglycemic Medication Use Among Medicare Beneficiaries With Heart Failure, Diabetes Mellitus, and Chronic Kidney Disease.
    Patel PA; Liang L; Khazanie P; Hammill BG; Fonarow GC; Yancy CW; Bhatt DL; Curtis LH; Hernandez AF
    Circ Heart Fail; 2016 Jul; 9(7):. PubMed ID: 27413035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Effectiveness of CRT-D Versus Defibrillator Alone in HF Patients With Moderate-to-Severe Chronic Kidney Disease.
    Friedman DJ; Singh JP; Curtis JP; Tang WHW; Bao H; Spatz ES; Hernandez AF; Patel UD; Al-Khatib SM
    J Am Coll Cardiol; 2015 Dec; 66(23):2618-2629. PubMed ID: 26670062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and Progression of Chronic Kidney Disease After Hepatitis C Seroconversion: Results from ERCHIVES.
    Rogal SS; Yan P; Rimland D; Lo Re V; Al-Rowais H; Fried L; Butt AA;
    Dig Dis Sci; 2016 Mar; 61(3):930-6. PubMed ID: 26526451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.
    Maddux FW; Shetty S; del Aguila MA; Nelson MA; Murray BM
    Ann Pharmacother; 2007 Nov; 41(11):1761-9. PubMed ID: 17895328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Participation in a Structured Weight Loss Program and All-Cause Mortality and Cardiovascular Morbidity in Obese Patients With Chronic Kidney Disease.
    MacLaughlin HL; Hall WL; Condry J; Sanders TA; Macdougall IC
    J Ren Nutr; 2015 Nov; 25(6):472-9. PubMed ID: 26143293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.